Efficacy and safety of first-line immunotherapy for advanced gastric or gastroesophageal cancer: System review network meta-analysis

被引:0
|
作者
Qin, Qiong
Sun, Yongkun
Yang, Lin
Zhong, Diansheng
机构
[1] Tianjin Med Univ, Gen Hosp, Tianjin, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Dept Med Oncol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Natl Clin Res Ctr Canc, Canc Hosp, Beijing, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e16014
引用
收藏
页数:1
相关论文
共 50 条
  • [11] Efficacy and safety of first-line treatments for patients with advanced hepatocellular carcinoma: A systematic review and network meta-analysis
    Li, Danni
    Li, Jingyi
    Liu, Yunpeng
    Qu, Xiujuan
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [12] Network Meta-Analysis of Efficacy and Safety of Chemotherapy and Target Therapy in the First-Line Setting of Advanced Pancreatic Cancer
    Lin, Kun-, I
    Yang, Jia-Lian
    Lin, Yu-Chao
    Chou, Che-Yi
    Chen, Jin-Hua
    Hung, Chin-Chuan
    CANCERS, 2019, 11 (11)
  • [13] The efficacy and safety of S-1-based regimens in the first-line treatment of advanced gastric cancer: a systematic review and meta-analysis
    Emil ter Veer
    Nadia Haj Mohammad
    Paul Lodder
    Lok Lam Ngai
    Mary Samaan
    Martijn G. H. van Oijen
    Hanneke W. M. van Laarhoven
    Gastric Cancer, 2016, 19 : 696 - 712
  • [14] The efficacy and safety of S-1-based regimens in the first-line treatment of advanced gastric cancer: a systematic review and meta-analysis
    ter Veer, Emil
    Mohammad, Nadia Haj
    Lodder, Paul
    Ngai, Lok Lam
    Samaan, Mary
    van Oijen, Martijn G. H.
    van Laarhoven, Hanneke W. M.
    GASTRIC CANCER, 2016, 19 (03) : 696 - 712
  • [15] Efficacy and safety of targeted drugs in advanced or metastatic gastric and gastroesophageal junction cancer: A network meta-analysis
    Gong, Hongxia
    Su, Yun
    Zhao, Lixia
    Ma, Li
    Zhang, Liying
    Hou, Liangying
    Li, Tingting
    Niu, Shiwei
    Zhang, Han
    Li, Chenghao
    Jin, Xiaojie
    Ge, Long
    Leng, Guangxian
    Liu, Yongqi
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2022, 47 (04) : 493 - 506
  • [16] Efficacy and Safety of First-Line Targeted Treatment and Immunotherapy for Patients with Biliary Tract Cancer: A Systematic Review and Meta-Analysis
    Yan, Xin
    Zou, Huimin
    Lai, Yunfeng
    Ung, Carolina Oi Lam
    Hu, Hao
    CANCERS, 2023, 15 (01)
  • [17] Efficacy and safety of first-line combined androgen blockade in advanced prostate cancer: A meta-analysis
    Sun, Y.
    Yang, Y.
    Chen, R.
    Zhao, L.
    Liu, F.
    Ren, S.
    Wang, H.
    Lu, X.
    Gao, X.
    Xu, C.
    ANNALS OF ONCOLOGY, 2017, 28
  • [18] Efficacy and Safety of First-Line Chemotherapies for Patients With Advanced Biliary Tract Carcinoma: A Systematic Review and Network Meta-Analysis
    Jiang, Yanfeng
    Zeng, Zhiming
    Zeng, Jie
    Liu, Cuizhen
    Qiu, Jinfeng
    Li, Ye
    Tang, Jing
    Mo, Ning
    Du, Lihua
    Ma, Jie
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [19] Efficacy and safety of first-line chemotherapies for patients with advanced pancreatic ductal adenocarcinoma: A systematic review and network meta-analysis
    Kang, Mao-Ji
    Li, Hao-Xin
    Gan, Yu
    Fang, Cheng
    Yang, Xiao-Li
    Li, Bo
    Su, Song
    HELIYON, 2024, 10 (08)
  • [20] Efficacy and safety of ramucirumab in gastric or gastroesophageal cancer: A systematic review and meta-analysis
    Wu, Rui
    Yuan, Sijia
    Wang, Yuxuan
    Nan, Yangli
    Chen, Zixiao
    Yuan, Hong
    Wang, Zixuan
    Li, Zuojing
    Zong, Dongsheng
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2024, 48 (08)